Clinical analysis of double level positive airway pressure in the treatment of chronic obstructive pulmonary disease with respiratory failure

Ling-Qun Hu, Tian Yu, Hua Guo, Xiao-Feng Zheng
{"title":"Clinical analysis of double level positive airway pressure in the treatment of chronic obstructive pulmonary disease with respiratory failure","authors":"Ling-Qun Hu, Tian Yu, Hua Guo, Xiao-Feng Zheng","doi":"10.3760/CMA.J.ISSN.1673-436X.2020.05.003","DOIUrl":null,"url":null,"abstract":"Objective \nTo observe the clinical effect of bi-level positive airway pressure (BiPAP) non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD) with respiratory failure. \n \n \nMethods \nA total of 120 patients with COPD and respiratory failure who were treated in the Department of Respiratory Medicine of the Sixth People′s Hospital of Chengdu from January 2016 to December 2018 were selected as the research subjects.They were randomly divided into 2 groups, and the control group (n=60) was given conventional medication Nasal catheter low-flow oxygen inhalation therapy, the experimental group (n=60) was given conventional medication+ BiPAP combined with NIV treatment; the heart rate (HR), respiration rate (RR), pH value, partial pressure of carbon dioxide (PaCO2), partial pressure of oxygen in artery (PaO2), arterial oxygen saturation (SaO2), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1%pred, Acute Physiology and Chronic Health Evaluation scoring system (APACHE Ⅱ), blood gas improvement time hospital stay, complications before the statistical test group and control group patients were observed. \n \n \nResults \nThe experimental group and the control group patients before treatment of HR, RR, pH and PaCO2, PaO2, SaO2, FVC, FEV1, FEV1%pred, APACHE Ⅱ there were no statistically significant difference comparing (t=1.306, 1.041, 1.058, 1.140, 1.026, 1.260, 1.021, 1.274, 1.165, 1.529, all P>0.05), but after treatment group comparison between HR, RR, pH, PaCO2, PaO2, SaO2, FVC, FEV1, FEV1%pred, APACHE Ⅱ each index difference were statistically significant (t=3.254, 3.985, 3.052, 4.162, 3.262, 5.124, 3.544, 3.127, 5.251, 3.184, all P<0.05). There were significant differences in blood gas improvement time, hospitalization time and complication rate between the experimental group and the control group (t=3.658, 5.187, χ2=26.359, both P<0.05). \n \n \nConclusions \nBiPAP NIV can effectively treat COPD complicated with respiratory failure, but attention should be paid to strengthen targeted nursing intervention to reduce the risk of related complications. \n \n \nKey words: \nPulmonary disease, chronic obstructive; Respiratory insufficiency; Bi-level positive airway pressure; Non-invasive ventilation; Clinical curative effect","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Asthma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-436X.2020.05.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To observe the clinical effect of bi-level positive airway pressure (BiPAP) non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD) with respiratory failure. Methods A total of 120 patients with COPD and respiratory failure who were treated in the Department of Respiratory Medicine of the Sixth People′s Hospital of Chengdu from January 2016 to December 2018 were selected as the research subjects.They were randomly divided into 2 groups, and the control group (n=60) was given conventional medication Nasal catheter low-flow oxygen inhalation therapy, the experimental group (n=60) was given conventional medication+ BiPAP combined with NIV treatment; the heart rate (HR), respiration rate (RR), pH value, partial pressure of carbon dioxide (PaCO2), partial pressure of oxygen in artery (PaO2), arterial oxygen saturation (SaO2), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1%pred, Acute Physiology and Chronic Health Evaluation scoring system (APACHE Ⅱ), blood gas improvement time hospital stay, complications before the statistical test group and control group patients were observed. Results The experimental group and the control group patients before treatment of HR, RR, pH and PaCO2, PaO2, SaO2, FVC, FEV1, FEV1%pred, APACHE Ⅱ there were no statistically significant difference comparing (t=1.306, 1.041, 1.058, 1.140, 1.026, 1.260, 1.021, 1.274, 1.165, 1.529, all P>0.05), but after treatment group comparison between HR, RR, pH, PaCO2, PaO2, SaO2, FVC, FEV1, FEV1%pred, APACHE Ⅱ each index difference were statistically significant (t=3.254, 3.985, 3.052, 4.162, 3.262, 5.124, 3.544, 3.127, 5.251, 3.184, all P<0.05). There were significant differences in blood gas improvement time, hospitalization time and complication rate between the experimental group and the control group (t=3.658, 5.187, χ2=26.359, both P<0.05). Conclusions BiPAP NIV can effectively treat COPD complicated with respiratory failure, but attention should be paid to strengthen targeted nursing intervention to reduce the risk of related complications. Key words: Pulmonary disease, chronic obstructive; Respiratory insufficiency; Bi-level positive airway pressure; Non-invasive ventilation; Clinical curative effect
双水平气道正压治疗慢性阻塞性肺疾病合并呼吸衰竭的临床分析
目的观察双水平气道正压通气(BiPAP)无创通气(NIV)治疗慢性阻塞性肺疾病(COPD)合并呼吸衰竭的临床效果。方法选取2016年1月至2018年12月成都市第六人民医院呼吸内科收治的慢性阻塞性肺病合并呼吸衰竭患者120例作为研究对象。随机分为2组,对照组(n=60)给予常规用药鼻导管低流量吸氧治疗,实验组(n=60)给予常规用药+ BiPAP联合NIV治疗;观察两组患者心率(HR)、呼吸频率(RR)、pH值、二氧化碳分压(PaCO2)、动脉氧分压(PaO2)、动脉血氧饱和度(SaO2)、用力肺活量(FVC)、用力呼气量(FEV1)、FEV1%pred、急性生理与慢性健康评估评分系统(APACHEⅡ)、血气改善时间、住院时间、并发症发生情况。结果实验组与对照组患者治疗前HR、RR、pH与PaCO2、PaO2、SaO2、FVC、FEV1、FEV1%pred、APACHEⅡ比较差异均无统计学意义(t=1.306、1.041、1.058、1.140、1.026、1.260、1.021、1.274、1.165、1.529,P均>0.05),但治疗组治疗后HR、RR、pH、PaCO2、PaO2、SaO2、FVC、FEV1、FEV1%pred、APACHEⅡ各指标比较差异均有统计学意义(t=3.254、3.985、3.052、4.162、3.262、5.124、3.544、3.127、5.251、3.184,P均<0.05)。两组患者血气改善时间、住院时间、并发症发生率比较,差异均有统计学意义(t=3.658、5.187,χ2=26.359, P均<0.05)。结论BiPAP NIV可有效治疗COPD合并呼吸衰竭,但应注意加强针对性护理干预,降低相关并发症的发生风险。关键词:肺部疾病;慢性阻塞性肺疾病;呼吸衰竭;双水平气道正压;非侵入式通风;临床疗效
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信